ANI PHARMACEUTICALS, INC Increase (Decrease) in Accounts Receivable
ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Accounts Receivable of -$6.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $19.08M, a 247.42% increase year-over-year.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$25.53M.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $27.86M, a 9.18% increase year-over-year.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $26.96M.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2025 was $58.53M, a 177.56% increase from fiscal 2024.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2024 was $21.09M.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2023 was -$3.36M, a 109.10% decline from fiscal 2022.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts receivable for fiscal 2022 was $36.91M, a 565.32% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$6.45M 10-Q · filed 2026-08-07 | $21.41M derived: sum of 3 quarters · filed 2026-08-07 | $48.37M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | -$25.53M 10-Q · filed 2026-05-08 | $2.33M derived: sum of 2 quarters · filed 2026-05-08 | $29.29M derived: sum of 3 quarters · filed 2026-05-08 | $34.78M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $27.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $54.82M derived: sum of 2 quarters · filed 2026-02-27 | $60.31M derived: sum of 3 quarters · filed 2026-08-07 | $58.53M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $26.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $32.46M derived: sum of 2 quarters · filed 2026-08-07 | $30.67M 10-Q · filed 2025-11-07 | $56.19M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $5.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.71M 10-Q · filed 2026-08-07 | $29.22M derived: sum of 3 quarters · filed 2026-08-07 | $20.78M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | -$1.78M 10-Q · filed 2026-05-08 | $23.73M derived: sum of 2 quarters · filed 2026-05-08 | $15.29M derived: sum of 3 quarters · filed 2026-05-08 | $8.97M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $25.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.07M derived: sum of 2 quarters · filed 2026-02-27 | $10.75M derived: sum of 3 quarters · filed 2026-02-27 | $21.09M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | -$8.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$14.77M derived: sum of 2 quarters · filed 2025-11-07 | -$4.43M 10-Q · filed 2025-11-07 | -$21.19M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | -$6.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $4.01M 10-Q · filed 2025-08-08 | -$12.75M derived: sum of 3 quarters · filed 2026-02-27 | -$6.83M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $10.34M 10-Q · filed 2025-05-09 | -$6.42M derived: sum of 2 quarters · filed 2026-02-27 | -$506.00K derived: sum of 3 quarters · filed 2026-02-27 | -$2.29M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | -$16.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$10.85M derived: sum of 2 quarters · filed 2026-02-27 | -$12.63M derived: sum of 3 quarters · filed 2026-02-27 | -$3.36M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $4.13M derived: sum of 2 quarters · filed 2024-11-08 | $13.40M 10-Q · filed 2024-11-08 | $38.41M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | -$1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $7.49M 10-Q · filed 2024-08-06 | $32.49M derived: sum of 3 quarters · filed 2025-02-28 | $22.51M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $9.28M 10-Q · filed 2024-05-10 | $34.28M derived: sum of 2 quarters · filed 2025-02-28 | $24.30M derived: sum of 3 quarters · filed 2025-02-28 | $43.09M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $15.03M derived: sum of 2 quarters · filed 2025-02-28 | $33.81M derived: sum of 3 quarters · filed 2025-02-28 | $36.91M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | -$9.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $8.81M derived: sum of 2 quarters · filed 2023-11-08 | $11.91M 10-Q · filed 2023-11-08 | $6.53M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $18.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $21.88M 10-Q · filed 2023-08-09 | $16.51M derived: sum of 3 quarters · filed 2024-02-29 | $30.58M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $3.10M 10-Q · filed 2023-05-08 | -$2.27M derived: sum of 2 quarters · filed 2024-02-29 | $11.79M derived: sum of 3 quarters · filed 2024-02-29 | $12.56M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | -$5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.69M derived: sum of 2 quarters · filed 2024-02-29 | $9.46M derived: sum of 3 quarters · filed 2024-02-29 | $5.55M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $14.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $14.84M derived: sum of 2 quarters · filed 2022-11-09 | $10.92M 10-Q · filed 2022-11-09 | $22.97M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$3.15M 10-Q · filed 2022-08-08 | $8.90M derived: sum of 3 quarters · filed 2023-03-09 | $19.49M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | -$3.92M 10-Q · filed 2022-05-10 | $8.13M derived: sum of 2 quarters · filed 2023-03-09 | $18.71M derived: sum of 3 quarters · filed 2023-03-09 | $9.50M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $12.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $22.63M derived: sum of 2 quarters · filed 2023-03-09 | $13.41M derived: sum of 3 quarters · filed 2023-03-09 | $23.66M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $10.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $1.37M derived: sum of 2 quarters · filed 2021-11-01 | $11.62M 10-Q · filed 2021-11-01 | $13.04M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-06-30 | -$9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.03M 10-Q · filed 2021-08-06 | $2.46M derived: sum of 3 quarters · filed 2022-03-15 | -$3.11M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-03-31 | $10.25M 10-Q · filed 2021-05-07 | $11.68M derived: sum of 2 quarters · filed 2022-03-15 | $6.11M derived: sum of 3 quarters · filed 2022-03-15 | $14.97M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2019-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$4.14M derived: sum of 2 quarters · filed 2022-03-15 | $4.72M derived: sum of 3 quarters · filed 2022-03-15 | $7.29M 10-K · filed 2022-03-15 | ||
| 2019-09-30 | -$5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.29M derived: sum of 2 quarters · filed 2020-11-05 | $5.86M 10-Q · filed 2020-11-05 | $3.05M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-06-30 | $8.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $11.43M 10-Q · filed 2020-08-06 | $8.63M derived: sum of 3 quarters · filed 2021-03-11 | $18.85M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-03-31 | $2.57M 10-Q · filed 2020-05-07 | -$237.00K derived: sum of 2 quarters · filed 2021-03-11 | $9.98M derived: sum of 3 quarters · filed 2021-03-11 | $11.30M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2018-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $7.42M derived: sum of 2 quarters · filed 2021-03-11 | $8.73M derived: sum of 3 quarters · filed 2021-03-11 | $4.74M 10-K · filed 2021-03-11 | ||
| 2018-09-30 | $10.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $11.54M derived: sum of 2 quarters · filed 2019-11-06 | $7.55M 10-Q · filed 2019-11-06 | $4.16M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$2.67M 10-Q · filed 2019-08-07 | -$6.06M derived: sum of 3 quarters · filed 2020-02-27 | $602.00K derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | -$3.99M 10-Q · filed 2019-05-09 | -$7.37M derived: sum of 2 quarters · filed 2020-02-27 | -$712.00K derived: sum of 3 quarters · filed 2020-02-27 | $8.10M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $3.27M derived: sum of 2 quarters · filed 2020-02-27 | $12.09M derived: sum of 3 quarters · filed 2020-02-27 | $12.89M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $6.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $15.48M derived: sum of 2 quarters · filed 2018-11-06 | $16.28M 10-Q · filed 2018-11-06 | $14.70M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $8.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $9.62M 10-Q · filed 2018-08-07 | $8.04M derived: sum of 3 quarters · filed 2019-02-27 | $19.95M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $802.00K 10-Q · filed 2018-05-08 | -$780.00K derived: sum of 2 quarters · filed 2019-02-27 | $11.13M derived: sum of 3 quarters · filed 2019-02-27 | $24.22M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $10.33M derived: sum of 2 quarters · filed 2019-02-27 | $23.41M derived: sum of 3 quarters · filed 2019-02-27 | $23.96M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $11.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $25.00M derived: sum of 2 quarters · filed 2017-11-02 | $25.55M 10-Q · filed 2017-11-02 | $25.83M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $13.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $13.63M 10-Q · filed 2017-08-03 | $13.92M derived: sum of 3 quarters · filed 2018-02-27 | $16.68M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $549.00K 10-Q · filed 2017-05-04 | $836.00K derived: sum of 2 quarters · filed 2018-02-27 | $3.60M derived: sum of 3 quarters · filed 2018-02-27 | $5.11M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.05M derived: sum of 2 quarters · filed 2018-02-27 | $4.56M derived: sum of 3 quarters · filed 2018-02-27 | $4.63M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.27M derived: sum of 2 quarters · filed 2016-11-03 | $4.35M 10-Q · filed 2016-11-03 | $7.08M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2015-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.58M 10-Q · filed 2016-08-04 | $4.31M derived: sum of 3 quarters · filed 2017-03-02 | $11.09M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2015-03-31 | $74.00K 10-Q · filed 2016-05-05 | $2.80M derived: sum of 2 quarters · filed 2017-03-02 | $9.58M derived: sum of 3 quarters · filed 2017-03-02 | $6.46M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $9.50M derived: sum of 2 quarters · filed 2017-03-02 | $6.39M derived: sum of 3 quarters · filed 2017-03-02 | $4.78M 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $6.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $3.66M derived: sum of 2 quarters · filed 2015-11-03 | $2.06M 10-Q · filed 2015-11-03 | $5.05M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | -$3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$4.72M 10-Q · filed 2015-08-04 | -$1.72M derived: sum of 3 quarters · filed 2016-02-23 | $1.37M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | -$1.61M 10-Q · filed 2015-05-05 | $1.39M derived: sum of 2 quarters · filed 2016-02-23 | $4.48M derived: sum of 3 quarters · filed 2016-02-23 | $5.00M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $6.09M derived: sum of 2 quarters · filed 2016-02-23 | $6.61M derived: sum of 3 quarters · filed 2016-02-23 | $7.08M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $3.61M derived: sum of 2 quarters · filed 2014-11-10 | $4.08M 10-Q · filed 2014-11-10 | $4.08M 10-Q · filed 2013-11-07 | $3.89M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $995.00K 10-Q · filed 2014-08-07 | $995.11K 10-Q · filed 2013-08-09 | $803.57K derived: sum of 3 quarters · filed 2014-08-07 | $1.29M derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $472.00K 10-Q · filed 2014-05-12 | $280.57K derived: sum of 2 quarters · filed 2014-05-12 | $766.94K derived: sum of 3 quarters · filed 2014-05-12 | |||
| 2012-12-31 | -$191.43K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $294.94K derived: sum of 2 quarters · filed 2014-02-28 | $327.00K 10-K · filed 2014-02-28 | |||
| 2012-09-30 | $486.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $518.43K 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $32.06K 10-Q · filed 2013-08-09 | |||||
| 2010-12-31 | $64.64K 10-K · filed 2013-02-28 | |||||
| 2009-12-31 | $285.84K 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |